logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10768183 B1

PDFFull Text
Date of Patent:
Sep. 08, 2020

Filed:

Nov. 25, 2016

Metabolite panel for improved screening and diagnostic testing of cystic fibrosis

Applicant:

Mcmaster University, Hamilton, CA;

Inventor:

Philip Britz-McKibbin, Hamilton, CA;

Assignee:

McMaster University, Hamilton, Ontario, CA;

Attorney:

Gowling WLG (Canada) LLP

Primary Examiner:

Thomas J Visone

Assistant Examiner:

Sharon M Papciak

Int. Cl.
CPC ...
G01N 33/68 (2006.01); G01N 33/50 (2006.01); G01N 27/447 (2006.01); A23L 33/10 (2016.01); A23L 33/00 (2016.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); A23L 33/10 (2016.08); A23L 33/40 (2016.08); G01N 33/50 (2013.01); G01N 33/6806 (2013.01); G16H 50/20 (2018.01); A23V 2002/00 (2013.01); G01N 27/4473 (2013.01); G01N 2560/00 (2013.01); G01N 2570/00 (2013.01); G01N 2800/382 (2013.01); G01N 2800/52 (2013.01); G16H 50/30 (2018.01);
Abstract

A method of diagnosing cystic fibrosis in a human subject is provided. The method includes the steps of: i) determining in a biological sample from the subject the level of one or more metabolic biomarkers; ii) comparing the level of the biomarker to a control level and determining the difference between the biomarker level and the control level; and iii) determining that the subject has cystic fibrosis or a related disorder when the difference in the level of the biomarker in the sample is statistically different from the control level.

Find Patent Forward Citations

Britz-McKibbin, Philip. (2020). Metabolite panel for improved screening and diagnostic testing of cystic fibrosis (U.S. Patent No. 10768183). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10768183

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…